Evidence map›Paper›PMID 30364713›Full record

ArticleJAAD case reports2018

Purpura fulminans-like lesions in antiphospholipid syndrome with endothelial C3 deposition.

Jorge Magdaleno-Tapial, Cristian Valenzuela-Oñate, Javier Pitarch-Fabregat, María Marín-Jiménez, Clara Molina Almela, Johana Isidora Gutiérrez-Salcedo, Javier Calvo-Catalá, José Luis Sánchez-Carazo, V Alegre-de Miquel

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JAAD case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jorge Magdaleno-TapialDepartment of Dermatology, Hospital General Universitario de Valencia, Valencia, Spain.
Cristian Valenzuela-OñateDepartment of Dermatology, Hospital General Universitario de Valencia, Valencia, Spain.
Javier Pitarch-FabregatDepartment of Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain.
María Marín-JiménezDepartment of Hematology, Hospital General Universitario de Valencia, Valencia, Spain.
Clara Molina AlmelaDepartment of Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain.
Johana Isidora Gutiérrez-SalcedoDepartment of Infectious Diseases, Hospital General Universitario de Valencia, Valencia, Spain.
Javier Calvo-CataláDepartment of Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain.
José Luis Sánchez-CarazoDepartment of Dermatology, Hospital General Universitario de Valencia, Valencia, Spain.
V Alegre-de MiquelDepartment of Dermatology, Hospital General Universitario de Valencia, Valencia, Spain.
Hospital General Universitario De Valencia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACL, anticardiolipin antibodyanticoagulationantiphospholipid syndromeanti-β2GPI, anti–β2-glycoprotein antibodyaPL, antiphospholipid antibodiesAPS, antiphospholipid syndromecomplement C3DIF, direct immunofluorescentLA, lupus anticoagulantpurpura fulminans

Identifiers

PMID30364713
PMCPMC6197947
OpenAlexW2897291176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.